1 minute read
Jan. 17, 2022
Respiratory Case Study: An Inhaled JAK Inhibitor from GSK
“compound 54c”
inhaled JAK inhibitor reduced AO metabolism in lung from kinase-focused screening and SBDD Journal of Medicinal Chemistry GlaxoSmithKline, Stevenage, UK
Reviewer:
Loading...
